NMRA
Neumora Therapeutics, Inc. · Healthcare
Arch Venture Partners X, LLC bought $25.5M of Neumora Therapeutics, Inc.
10% owner
Bought$25,500,000
$17.00Price
1,500,000Shares
+5%Stake
What NMRA did for a copier
- $1,000 copied at Wed, Sep 20 open, $12.80
- $843
- S&P 500, same days
- −4.8%
Measured over 30 trading days, to the Nov 1 close.
Arch Venture Partners X, LLC's record
3 other buys with 3 months of prices since 2024: on average −15.3% against the S&P 500, and 0 of 3 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Sep 19. Filed Wed, Sep 20, 6:15 AM ET, before the open. Returns use the Sep 20 open and the Nov 1 close. Not investment advice.